Thanks for you thoughts Buildit. Good stuff there.
Post# of 36537
(Total Views: 290)
Posted On: 12/11/2019 6:59:45 AM
Thanks for you thoughts Buildit. Good stuff there.
One of the things Generex has failed miserably with is providing timely and specific information. Multiple reasons for such. Some are reasonable. Some may be questionable. I think should the SEC review certain statements, timeframes etc and subsequent changes in the companies directions there may be an interesting story unfold. I will send my thoughts to the SEC by 12/23 if we haven't gotten clarification on a number of matters by then.
We'll see if management can produce and rebuild shareholder value which as all but been wiped out year over year.
Glad you are hanging in there!
One of the things Generex has failed miserably with is providing timely and specific information. Multiple reasons for such. Some are reasonable. Some may be questionable. I think should the SEC review certain statements, timeframes etc and subsequent changes in the companies directions there may be an interesting story unfold. I will send my thoughts to the SEC by 12/23 if we haven't gotten clarification on a number of matters by then.
We'll see if management can produce and rebuild shareholder value which as all but been wiped out year over year.
Glad you are hanging in there!
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼